SCHEMBL7981350

SCHEMBL7981350

COc1ccc(Br)c(Nc2nc3ccccc3n3cncc23)c1

nearest known ligand 0.69

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LCK P06239 19/20 0.69
KDM4E B2RXH2 1/20 0.53
MAPT P10636 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7979701 0.87 LCK (0.69) LCKKDM4EMAPT
SCHEMBL7970028 0.86 LCK (0.77) LCKKDM4EMAPT
SCHEMBL7983549 0.85 LCK (0.77) LCK
SCHEMBL7970096 0.80 LCK (0.65) LCK
SCHEMBL7969915 0.79 LCK (1.00) LCKKDM4EMAPT
SCHEMBL7983627 0.79 LCK (0.76) LCK
SCHEMBL7983541 0.78 LCK (0.77) LCK
SCHEMBL7983951 0.78 LCK (0.73) LCK
SCHEMBL7987300 0.78 LCK (0.73) LCK
SCHEMBL7969745 0.77 LCK (0.80) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed